Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Announces Target Price $17

Futu NewsNov 14 22:31 · Ratings

Sector Update: Health Care Stocks Advance Pre-Bell Thursday

MT NewswiresNov 14 22:20

Sector Update: Health Care

MT NewswiresNov 14 21:51

Top Premarket Gainers

MT NewswiresNov 14 20:56

ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain

AccesswireNov 14 02:20

The ClearPoint Neuro, Inc. (NASDAQ:CLPT) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Yahoo FinanceNov 10 21:02